The US has launched a Section 301 investigation into Germany concerning alleged underpayment for innovative pharmaceuticals, potentially impacting US commerce. Germany's proposed healthcare reforms and fast-tracking of legislation to reduce drug spending are key concerns.
Breckenridge Pharmaceuticals thu hồi gần 370.000 lọ thuốc Duloxetine do tạp chất N-nitroso-duloxetine có thể gây ung thư. FDA xếp loại thu hồi là Nhóm II, ảnh hưởng tạm thời hoặc có thể khắc phục về y tế.
Taiwanese entrepreneur Lai Caida shared his entrepreneurial journey at the 18th Straits Forum in Xiamen, aiming to become the "SpaceX of the pharmaceutical industry" with his AI-powered drug delivery platform, Jitaikeji. The company, which started in Hangzhou, has now listed in Hong Kong and Lai invited other Taiwanese youth to pursue opportunities in mainland China.
Trade turnover between Russia and Uzbekistan surged by nearly 30% in the first quarter of this year, following a 12% increase last year to $11.5 billion. Joint projects span industry, energy, transport, and agriculture.
India and Venezuela are expanding cooperation, especially in energy, with Venezuela becoming India's third-largest crude oil supplier. Discussions aim for a structured energy partnership, covering upstream and downstream sectors, leveraging Venezuela's vast oil reserves and India's growing demand.
Russia's Economic Development Minister Maxim Reshetnikov stated readiness to enhance agricultural cooperation with Brazil, focusing on increased imports of coffee, fruits, and meat, and collaboration in plant breeding and education. Russia also seeks dialogue on drug registration with Brazil's health agency.
Indian companies are set to invest over $20.5 billion dollars in the United States in various sectors including technology, manufacturing, and pharmaceuticals. "Twelve Indian firms alone announced 1.1 billion dollars in new investments today and these partnerships are creating American jobs and strengthening supply chains," US ambassador to India Sergio Gor said.
The FDA approved the first gene therapy to restore hearing for people born deaf, developed by Regeneron Pharmaceuticals. The treatment targets a rare genetic defect affecting about 50 U.S. children annually, caused by a defective OTOF gene. In clinical trials, 80% of patients achieved significant hearing restoration and 42% gained normal hearing, with effects lasting at least two years.
Servier a mené «avec succès» son offre publique d’achat visant la totalité des actions de l’entreprise biopharmaceutique américaine Day One Biopharmaceuticals.
